Related references
Note: Only part of the references are listed.Evaluation of [Tc-99m]Radiolabeled Macrophage Mannose Receptor-Specific Nanobodies for Targeting of Atherosclerotic Lesions in Mice
Gezim Bala et al.
MOLECULAR IMAGING AND BIOLOGY (2018)
Translating Molecular Imaging of the Vulnerable Plaque-a Vulnerable Project?
Gezim Bala et al.
MOLECULAR IMAGING AND BIOLOGY (2018)
Improved Debulking of Peritoneal Tumor Implants by Near-Infrared Fluorescent Nanobody Image Guidance in an Experimental Mouse Model
Pieterjan Debie et al.
MOLECULAR IMAGING AND BIOLOGY (2018)
New methods to image unstable atherosclerotic plaques
Jack P. M. Andrews et al.
ATHEROSCLEROSIS (2018)
Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in Oncology
Ahmet Krasniqi et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Evaluation of Antiatherogenic Properties of Ezetimibe Using 3H-Labeled Low-Density-Lipoprotein Cholesterol and 99mTc-cAbVCAM1-5 SPECT in ApoE-/- Mice Fed the Paigen Diet
Laurent S. Dumas et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Chemically-defined camelid antibody bioconjugate for the magnetic resonance imaging of Alzheimer's disease
Matthias Vandesquille et al.
MABS (2017)
Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma
Ahmet Krasniqi et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Effect of Dye and Conjugation Chemistry on the Biodistribution Profile of Near-Infrared-Labeled Nanobodies as Tracers for Image-Guided Surgery
Pieterjan Debie et al.
MOLECULAR PHARMACEUTICS (2017)
131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment
Matthias D'Huyvetter et al.
CLINICAL CANCER RESEARCH (2017)
18F-Labeling of Sensitive Biomolecules for Positron Emission Tomography
Hema S. Krishnan et al.
CHEMISTRY-A EUROPEAN JOURNAL (2017)
Phase I Study of Ga-68-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma
Marleen Keyaerts et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Technical Aspects of Cardiac PET Imaging and Recent Advances
Guido Germano et al.
CARDIOLOGY CLINICS (2016)
Sortase A-mediated site-specific labeling of camelid single-domain antibody-fragments: a versatile strategy for multiple molecular imaging modalities
Sam Massa et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2016)
Nanobodies as therapeutics: big opportunities for small antibodies
Sophie Steeland et al.
DRUG DISCOVERY TODAY (2016)
Variation of Specific Activities of 68Ga-Aquibeprin and 68Ga-Avebetrin Enables Selective PET Imaging of Different Expression Levels of Integrins α5β1 and αvβ3
Johannes Notni et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques
Gezim Bala et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2016)
Gallium-68 in Medical Imaging
Lucia Martiniova et al.
CURRENT RADIOPHARMACEUTICALS (2016)
Radiometals: towards a new success story in nuclear imaging?
David Brasse et al.
DALTON TRANSACTIONS (2015)
PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments
Anneleen Blykers et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Matching chelators to radiometals for radiopharmaceuticals
Eric W. Price et al.
CHEMICAL SOCIETY REVIEWS (2014)
99mTc-cAbVCAM1-5 Imaging Is a Sensitive and Reproducible Tool for the Detection of Inflamed Atherosclerotic Lesions in Mice
Alexis Broisat et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Functional knock down of VCAM1 in mice mediated by endoplasmatic reticulum retained intrabodies
Andrea Lj Marschall et al.
MABS (2014)
PET imaging of inflammation in atherosclerosis
Jason M. Tarkin et al.
NATURE REVIEWS CARDIOLOGY (2014)
Nanobody: The Magic Bullet for Molecular Imaging?
Rubel Chakravarty et al.
THERANOSTICS (2014)
Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amount
Mark W. Konijnenberg et al.
EJNMMI RESEARCH (2014)
Synthesis, Preclinical Validation, Dosimetry, and Toxicity of 68Ga-NOTA-Anti-HER2 Nanobodies for iPET Imaging of HER2 Receptor Expression in Cancer
Catarina Xavier et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Molecular Imaging of Atherosclerosis for Improving Diagnostic and Therapeutic Development
Thibaut Quillard et al.
CIRCULATION RESEARCH (2012)
Nanobodies Targeting Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions
Alexis Broisat et al.
CIRCULATION RESEARCH (2012)
Nanobody-coupled microbubbles as novel molecular tracer
Sophie Hernot et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels
Vladimir Tolmachev et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer
Ilse Vaneycken et al.
FASEB JOURNAL (2011)
Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-ZEGFR:2377 Affibody molecule: aspect of the injected tracer amount
Vladimir Tolmachev et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Regional quantitative analysis of small animal myocardial sympathetic innervation and initial application in streptozotocin induced diabetes
Lode R. Goethals et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2009)
Mass effect of injected dose in small rodent imaging by SPECT and PET
MP Kung et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
From vulnerable plaque to vulnerable patient - A call for new definitions and risk assessment strategies: Part I
M Naghavi et al.
CIRCULATION (2003)
Share Paper
